Clinical Trials Logo

Diabetic Foot Ulcers clinical trials

View clinical trials related to Diabetic Foot Ulcers.

Filter by:

NCT ID: NCT02631512 Completed - Clinical trials for Diabetic Foot Ulcers

Evaluation of Woulgan in Diabetic Foot Ulcer

Start date: October 2015
Phase: Phase 4
Study type: Interventional

The aim of the current study is to support the performance and safety of Woulgan® in the treatment of diabetic foot ulcer in comparison with the commercially available hydrogel Intrasite. Healing and untoward medical events to be evaluated.

NCT ID: NCT02589210 Completed - Clinical trials for Diabetic Foot Ulcers

dHACM Mesh In the Treatment of Diabetic Foot Ulcers

Start date: May 2015
Phase: N/A
Study type: Interventional

A single-centered, non-randomized study with approximately 20 subjects that will be seen for up to 12 weeks, each receiving the EpiFix mesh plus standard of care. Safety and effectiveness will be monitored throughout the study.

NCT ID: NCT02587104 Completed - Clinical trials for Diabetic Foot Ulcers

dHACM In the Treatment of Diabetic Foot Ulcers

Start date: June 2015
Phase: N/A
Study type: Interventional

A single-centered, non-randomized study with approximately 20 subjects that will be seen for up to 12 weeks, each receiving the EpiFix plus standard of care. Safety and effectiveness will be monitored throughout the study.

NCT ID: NCT02577120 Suspended - Clinical trials for Diabetic Foot Ulcers

Wound Healing Endpoint and Recurrence

Start date: January 8, 2019
Phase: Phase 4
Study type: Interventional

This prospective pilot study is to enroll patients with clinically-defined infected wounds. Patients enrolled in the study will be followed for 16 weeks for wound closure (Phase A), and will then begin Phase B. 265 clinically diagnosed infected burn or chronic wound patients will be recruited for this study in Phase A. Based on the expectation that 89% of these wounds will heal within 16 weeks of enrollment, 234 of these patients will continue with the study for Phase B.

NCT ID: NCT02506452 Active, not recruiting - Clinical trials for Diabetic Foot Ulcers

Postmarket Study to Evaluate Biovance® in Diabetic Foot Ulcers

Start date: June 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the wound closure outcomes of subjects receiving diabetic foot ulcer treatment with and without the use of Biovance®.

NCT ID: NCT02470806 Completed - Clinical trials for Diabetic Foot Ulcers

Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)

NPWT
Start date: July 2, 2015
Phase: N/A
Study type: Interventional

The aim of this study is to compare the clinical efficacy of two types of NPWT systems; the traditional negative pressure wound therapy (tNPWT) system and the single-use negative pressure wound therapy (PICO) system.

NCT ID: NCT02467998 Recruiting - Burns Clinical Trials

Negative Pressure Wound Therapy Registry

NPWTR
Start date: January 2005
Phase:
Study type: Observational [Patient Registry]

The goal of the Negative Pressure Wound Therapy Registry (NPWTR) for Wounds is to provide real world patient data from electronic health records submitted to meet Stage 2 Meaningful Use in order to understand the effectiveness and safety of various NPWT devices and methods among patients with chronic wounds and ulcers. Randomized, controlled trials to establish product efficacy routinely exclude patients with the co-morbid conditions common to patients seen in usual clinical practice and thus the results of these Randomized Controlled Trials (RCTs) tend to be non-generalizable. Little is known about the effectiveness of NPWT among typical patients. Patient registries are also ideal for assessing long term safety issues in these devices.

NCT ID: NCT02463500 Completed - Clinical trials for Diabetic Foot Ulcers

UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository

DFUDatabase
Start date: January 2015
Phase:
Study type: Observational [Patient Registry]

This will be a continuing, prospective study of diabetic foot ulcers and infections, risk factors and clinical outcomes and a limited data set conducted by the investigator through the establishment of a data and tissue repository in the uT Southwestern Department of Plastic Surgery. in addition, subjects consented for this research will be asked about inclusion in a recruitment database to be used in the recruitment of subjects for future research on diabetic foot complications. about 250 patients are seen for diabetic foot ulcers and infections each year.

NCT ID: NCT02463487 Completed - Clinical trials for Diabetic Foot Ulcers

Negative Pressure Wound Therapy as a Drug Delivery System

Start date: June 2, 2015
Phase: N/A
Study type: Interventional

The investigators plan a randomized clinical trial of 150 patients with infected diabetes-related lower extremity wounds to compare the clinical and economic effectiveness of negative pressure wound therapy with continuous irrigation and negative pressure wound therapy without irrigation.

NCT ID: NCT02402374 Enrolling by invitation - Clinical trials for Diabetic Foot Ulcers

Evaluate the Safety and Efficacy of RegenKit Autologous PRP Gel for the Treatment of Diabetic Foot Ulcer

Start date: April 12, 2018
Phase: N/A
Study type: Interventional

Autologous platelet-rich plasma (PRP) gel was reported to have very good outcomes in the treatment of foot ulcers in pilot studies and retrospective uncontrolled trials. Therefore, a larger randomized, placebo-controlled clinical trial will be useful to determine whether platelet-rich plasma is safe and effective for the treatment of diabetic foot ulcers (DFU).